Prof. Luigi Schips Dept of Urology – “S.Pio da Pietrelcina” Hospital Vasto - Italy PRO Single...
-
Upload
oscar-maxwell -
Category
Documents
-
view
227 -
download
0
Transcript of Prof. Luigi Schips Dept of Urology – “S.Pio da Pietrelcina” Hospital Vasto - Italy PRO Single...
Prof. Luigi SchipsDept of Urology – “S.Pio da
Pietrelcina” HospitalVasto - Italy
Single port nephrectomy:
is it worth it? PROPRO
The first
… but a first experience in children was described in the 2006
Today, a growing and ongoing experience
Great interest from Companies, patients and surgeons
The most exploredSimple nephrectomyPartial nephrectomy ± ischemiaRadical nephrectomyCitoreductive nephrectomyNephroureterectomyNephrectomy in childrenPelvic kidney nephrectomyLiving donor nephrectomyRenal crioablation Renal biopsy
Transperitoneal
Retroperitoneal
Robotic
NOTES-hybrid
Different trocars
The most commonly performed
2009 Desai , 42 pts2009 White,74 pts
2009 Stolzenburg, 10 pts2009 Ryu, 5 pts2010 Lee, 4 pts
2010 Canes 18 (donor)2010 Raybourn, 11 pts
2010 Jeong, 21 pts2011 Choi,123 pts2011 Seo, 11 pts
2011 Kurien, 24 pts (donor) 2011 Schips, 25 pts
Surgical outcomes
Operative time
Blood loss
Complication rate
Conversion to open
No differences
Better in LESS group
No differences
Better in LESS group
Raman 2009, Andonian 2010, Tugcu 2010, Park 2010, Raybourn 2010, Seo 2011, Kurien 2011
Surgical outcomes
Hospital stay
Transfusion rate
Postop. pain
Cosmesis
No differences
Better in LESS group
Better in LESS group
Better in LESS group
Raman 2009, Andonian 2010, Tugcu 2010, Park 2010, Raybourn 2010, Seo 2011, Kurien 2011
How to have robust evidence in surgical innovation: RCT?
Research on surgery is associated with several methodological and practical challenges
Large, high-quality RCTs have been done in a variety of surgical specialties, but those of the surgical procedure itself are uncommon
It is difficult to decide when to shift from an early exploratory stage of development to a formal investigation. If too early, the constraints of an RCT could obstruct innovation, and if too late, equipoise could be lost.
Future perspectives
History of LESS started only 3 yr ago
We arguably are still completing our learning curve
The potential benefit for LESS goes much further than cosmesis
Not cosmesis but less morbidity to our patients!
Urologists = pioneers of experimental and clinical
development of LESS
Urologists = translators of new skills and
knowledge into a clinical benefit for patients
It is not all about the scar